Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024:
Abbott study shows benefits of OCT imaging in stent placement
Dive Brief: Abbott said optical coherence tomography (OCT) imaging improved physicians’ ability to place and expand stents, compared to angiography, in a clinical trial. OCT